128 related articles for article (PubMed ID: 36360276)
1. Risk Allele Frequency Analysis and Risk Prediction of Single-Nucleotide Polymorphisms for Prostate Cancer.
Yoon BW; Shin HT; Seo JH
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360276
[TBL] [Abstract][Full Text] [Related]
2. Risk Allele Frequency Analysis of Single-Nucleotide Polymorphisms for Vitamin D Concentrations in Different Ethnic Group.
Yoon BW; Shin HT; Seo J
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680925
[TBL] [Abstract][Full Text] [Related]
3. Analysis of risk allele frequencies of single nucleotide polymorphisms related to open-angle glaucoma in different ethnic groups.
Shin HT; Yoon BW; Seo JH
BMC Med Genomics; 2021 Mar; 14(1):80. PubMed ID: 33726755
[TBL] [Abstract][Full Text] [Related]
4. Application of European-specific polygenic risk scores for predicting prostate cancer risk in different ancestry populations.
Ruan X; Huang D; Huang J; Xu D; Na R
Prostate; 2023 Jan; 83(1):30-38. PubMed ID: 35996327
[TBL] [Abstract][Full Text] [Related]
5. Comparison of risk allele frequencies of single nucleotide polymorphisms associated with age-related macular degeneration in different ethnic groups.
Shin HT; Yoon BW; Seo JH
BMC Ophthalmol; 2021 Feb; 21(1):97. PubMed ID: 33618707
[TBL] [Abstract][Full Text] [Related]
6. Polygenic risk score for genetic evaluation of prostate cancer risk in Asian populations: A narrative review.
Song SH; Byun SS
Investig Clin Urol; 2021 May; 62(3):256-266. PubMed ID: 33943048
[TBL] [Abstract][Full Text] [Related]
7. Genetic Hitchhiking and Population Bottlenecks Contribute to Prostate Cancer Disparities in Men of African Descent.
Lachance J; Berens AJ; Hansen MEB; Teng AK; Tishkoff SA; Rebbeck TR
Cancer Res; 2018 May; 78(9):2432-2443. PubMed ID: 29438991
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of polygenic risk scores for predicting breast and prostate cancer risk.
Machiela MJ; Chen CY; Chen C; Chanock SJ; Hunter DJ; Kraft P
Genet Epidemiol; 2011 Sep; 35(6):506-514. PubMed ID: 21618606
[TBL] [Abstract][Full Text] [Related]
9. Prediction of clinically significant prostate cancer using polygenic risk models in Asians.
Song SH; Kim E; Woo E; Kwon E; Yoon S; Kim JK; Lee H; Oh JJ; Lee S; Hong SK; Byun SS
Investig Clin Urol; 2022 Jan; 63(1):42-52. PubMed ID: 34983122
[TBL] [Abstract][Full Text] [Related]
10. Combined CRISPRi and proteomics screening reveal a cohesin-CTCF-bound allele contributing to increased expression of RUVBL1 and prostate cancer progression.
Tian Y; Dong D; Wang Z; Wu L; Park JY; ; Wei GH; Wang L
Am J Hum Genet; 2023 Aug; 110(8):1289-1303. PubMed ID: 37541187
[TBL] [Abstract][Full Text] [Related]
11. The RTK/ERK pathway is associated with prostate cancer risk on the SNP level: a pooled analysis of 41 sets of data from case-control studies.
Chen Y; Li T; Yu X; Xu J; Li J; Luo D; Mo Z; Hu Y
Gene; 2014 Jan; 534(2):286-97. PubMed ID: 24177231
[TBL] [Abstract][Full Text] [Related]
12. Genetic risk of prostate cancer in Ugandan men.
Du Z; Lubmawa A; Gundell S; Wan P; Nalukenge C; Muwanga P; Lutalo M; Nansereko D; Ndaruhutse O; Katuku M; Nassanga R; ; Asiimwe F; Masaba B; Kaggwa S; Namuguzi D; Kiddu V; Mutema G; Conti DV; Luke A; Job K; Henry DM; Haiman CA; Watya S
Prostate; 2018 Apr; 78(5):370-376. PubMed ID: 29356057
[TBL] [Abstract][Full Text] [Related]
13. How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis.
Siltari A; Lönnerbro R; Pang K; Shiranov K; Asiimwe A; Evans-Axelsson S; Franks B; Kiran A; Murtola TJ; Schalken J; Steinbeisser C; Bjartell A; Auvinen A;
Clin Genitourin Cancer; 2023 Apr; 21(2):316.e1-316.e11. PubMed ID: 36243664
[TBL] [Abstract][Full Text] [Related]
14. Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer.
Conran CA; Na R; Chen H; Jiang D; Lin X; Zheng SL; Brendler CB; Xu J
Asian J Androl; 2016; 18(4):520-4. PubMed ID: 27080480
[TBL] [Abstract][Full Text] [Related]
15. Genetic risk assessment of lethal prostate cancer using polygenic risk score and hereditary cancer susceptibility genes.
Ruan X; Huang D; Huang J; Tsu JH; Na R
J Transl Med; 2023 Jul; 21(1):446. PubMed ID: 37415201
[TBL] [Abstract][Full Text] [Related]
16. Post genome-wide association studies functional characterization of prostate cancer risk loci.
Jiang J; Cui W; Vongsangnak W; Hu G; Shen B
BMC Genomics; 2013; 14 Suppl 8(Suppl 8):S9. PubMed ID: 24564736
[TBL] [Abstract][Full Text] [Related]
17. Association of prostate cancer risk with SNPs in regions containing androgen receptor binding sites captured by ChIP-On-chip analyses.
Lu Y; Sun J; Kader AK; Kim ST; Kim JW; Liu W; Sun J; Lu D; Feng J; Zhu Y; Jin T; Zhang Z; Dimitrov L; Lowey J; Campbell K; Suh E; Duggan D; Carpten J; Trent JM; Gronberg H; Zheng SL; Isaacs WB; Xu J
Prostate; 2012 Mar; 72(4):376-85. PubMed ID: 21671247
[TBL] [Abstract][Full Text] [Related]
18. Genetic variations in androgen metabolism genes and associations with prostate cancer in South African men.
Fernandez P; De Beer PM; Van der Merwe L; Heyns CF
S Afr Med J; 2010 Nov; 100(11):741-5. PubMed ID: 21081028
[TBL] [Abstract][Full Text] [Related]
19. Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk.
Pierce BL; Ahsan H
Hum Hered; 2010; 69(3):193-201. PubMed ID: 20203524
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers.
Nomura M; Shigematsu H; Li L; Suzuki M; Takahashi T; Estess P; Siegelman M; Feng Z; Kato H; Marchetti A; Shay JW; Spitz MR; Wistuba II; Minna JD; Gazdar AF
PLoS Med; 2007 Apr; 4(4):e125. PubMed ID: 17455987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
